Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
Total Valuation
Resmed has a market cap or net worth of $31.28B. The enterprise value is $34.05B.
Market Cap$31.28B
Enterprise Value$34.05B
Share Statistics
Resmed has 146.87M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding146.87M
Owened by Insiders0.52%
Owened by Instutions9.40%
Financial Efficiency
Resmed’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 17.69%.
Return on Equity (ROE)20.99%
Return on Assets (ROA)14.86%
Return on Invested Capital (ROIC)17.69%
Return on Capital Employed (ROCE)22.14%
Revenue Per Employee$493,664.629
Profits Per Employee$125,120.741
Employee Count9,980
Asset Turnover0.68
Inventory Turnover2.47
Valuation Ratios
The current PE Ratio of Resmed is 26.92. Resmed’s PEG ratio is 2.01.
PE Ratio26.92
PS Ratio5.87
PB Ratio5.65
Price to Fair Value5.65
Price to FCF21.37
Price to Operating Cash Flow19.61
PEG Ratio2.01
Income Statement
In the last 12 months, Resmed had revenue of $4.93B and earned $1.25B in profits. Earnings per share was $8.58.
Revenue$4.93B
Gross Profit$2.85B
Operating Income$1.56B
Pretax Income$1.53B
Net Income$1.25B
EBITDA1.66B
Earnings Per Share (EPS)8.58
Cash Flow
In the last 12 months, operating cash flow was $1.48B and capital expenditures -$87.92M, giving a free cash flow of $1.39B billion.
Operating Cash Flow$1.48B
Free Cash Flow$1.39B
Free Cash Flow per Share$9.45
Dividends & Yields
Resmed pays an annual dividend of $0.53, resulting in a dividend yield of 1.01%
Dividend Per Share$0.53
Dividend Yield1.01%
Payout Ratio23.37%
Free Cash Flow Yield4.68%
Earnings Yield3.71%
Stock Price Statistics
Beta1.11
52-Week Price Change12.11%
50-Day Moving Average227.74
200-Day Moving Average230.16
Relative Strength Index (RSI)45.21
Average Volume (3m)999.87K
Important Dates
Resmed upcoming earnings date is Apr 23, 2025, After Close.
Last Earnings DateJan 30, 2025
Next Earnings DateApr 23, 2025
Ex-Dividend DateFeb 13, 2025
Financial Position
Resmed as a current ratio of 2.59, with Debt / Equity ratio of 0.18
Current Ratio2.59
Quick Ratio1.69
Debt to Market Cap0.03
Net Debt to EBITDA0.41
Interest Coverage Ratio28.88
Taxes
In the past 12 months, Resmed has paid $286.27M in taxes.
Income Tax$286.27M
Effective Tax Rate19.28%
Enterprise Valuation
Resmed EV to EBITDA ratio is 18.34, with an EV/FCF ratio of 21.86.
EV to Sales6.00
EV to EBITDA18.34
EV to Free Cash Flow21.86
EV to Operating Cash Flow20.07
Balance Sheet
Resmed has $521.94M in cash and marketable securities with $839.74M in debt, giving a net cash position of $317.79M billion.
Cash & Marketable Securities$521.94M
Total Debt$839.74M
Net Cash$317.79M
Net Cash Per Share$2.16
Tangible Book Value Per Share$10.45
Margins
Gross margin is 56.67%, with operating margin of 28.17%, and net profit margin of 21.79%.
Gross Margin56.67%
Operating Margin28.17%
Pretax Margin27.00%
Net Profit Margin21.79%
EBITDA Margin32.73%
EBIT Margin27.97%
Analyst Forecast
The average price target for Resmed is $272.90, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$272.90
Price Target Upside26.09%
Analyst ConsensusModerate Buy
Analyst Count13
Revenue Growth Forecast9.38%
EPS Growth Forecast40.38%